Press release
Female Infertility Menopause Contraceptive Drugs Market is Set to Experience Revolutionary Growth by 2021
Menopause, also termed as climacteric, refers to cessation of menstruation. It usually occurs in females aged between 45 and 55 years. Female infertility refers to a condition of infertility in females. Various causes for female infertility are polycystic ovary syndrome (PCOS), hypothalamic dysfunction, premature ovarian insufficiency, and hyperprolactinemia. Contraceptives are drugs and devices that are used to prevent pregnancy and sexually transmitted infections. Contraceptive drugs are further classified as contraceptive pills, topical contraceptives, and contraceptive injectables. The female infertility, menopause, and contraceptive drugs market is growing at a significant rate due to increasing disorders related to fertility and menopause and rising awareness about different menopause, female infertility and contraceptive drugs. In addition, government initiatives for improving female health are driving the market for female infertility, menopause, and contraceptive drugs.North America dominates the global market for female infertility, menopause and contraceptive drugs due to the increasing prevalence of disorders related to menopause and female infertility in the region. In addition, high usage of contraceptive pills in the region due to the high efficiency provided by the drugs is driving the overall market for contraceptives. Asia, followed by Europe, is expected to experience high growth rate in the next few years in the female infertility, menopause, and contraceptive drugs market. China and India are expected to be the fastest growing female infertility, menopause, and contraceptive drugs markets in Asia. Some of the key driving forces for the female infertility, menopause and contraceptive drugs market in emerging countries are large pool of patients and rising government initiatives by funding and strict laws.
Increasing awareness about different disorders in female fertility, menopause, and complications in female health by not using birth control measures is contributing to the growth of the market for female infertility, menopause and contraceptive drugs. In addition, the increasing prevalence of female sexual disorders and improvement in healthcare facilities and technological advancements in the field have been driving the female infertility, menopause, and contraceptive drugs market. However, the side effects associated with the intake of contraceptive drugs and lower adoption rates for drugs associated with treatment of female infertility and menopause have been restraining the market.
Growing populations and developing economies in countries such as India and China are expected to offer good opportunities for the global female infertility, menopause, and contraceptive drugs market. The arrival on the market of some new products with better efficiency is expected to offer good opportunity for the global female infertility, menopause, and contraceptive drugs market. The growing number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that observed in the global female infertility, menopause and contraceptive drugs market. The side effects associated with intake of female infertility, menopause, and contraceptive drugs are a challenge for the market.
Request Sample Report @https://www.persistencemarketresearch.com/samples/4280
Some of the major companies dealing in global menopause, fertility and contraceptive drugs market include Aventis SA, Bristol-Myers Squibb Company, Johnson & Johnson, and Merck & Company, Inc. Other significant players in the global menopause, fertility, and contraceptive drugs market include Novartis International AG, Bayers AG, Pharmacia & Upjohn, Inc., Organon, Inc., Berlex Laboratories, Parke-Davis, G. D. Searle & Company, TAP Holdings Inc., The Ares-Serono Group, and American Home Products Corporation.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada
Toll Free: 800-961-0353
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Female Infertility Menopause Contraceptive Drugs Market is Set to Experience Revolutionary Growth by 2021 here
News-ID: 1082595 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Contraceptive
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede
As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the…
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid…
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost…
